LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Search

CVS Health Corp.

Uždarymo kaina

SektoriusSveikatos priežiūra

78.75 0.75

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

78.02

Max

79.22

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3.8B

-2.8B

Pardavimai

4B

103B

P/E

Sektoriaus vid.

206.421

77.256

Pelnas, tenkantis vienai akcijai

1.6

Dividendų pajamingumas

3.4

Pelno marža

-2.722

Darbuotojai

219,000

EBITDA

-4B

-1.6B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+13.41% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.40%

2.33%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-5B

100B

Ankstesnė atidarymo kaina

78

Ankstesnė uždarymo kaina

78.75

Naujienos nuotaikos

By Acuity

42%

58%

143 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

CVS Health Corp. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-29 10:48; UTC

Uždarbis

CVS Posts Loss on Write-Down, Boosts Guidance as Adjusted Earnings Rise

2025-10-30 20:45; UTC

Uždarbis

Gilead Earnings Beat Expectations. The Stock Is Still Falling. -- Barrons.com

2025-10-30 20:30; UTC

Uždarbis

Gilead Earnings Beat Expectations. The Stock Is Still Falling. -- Barrons.com

2025-10-30 14:52; UTC

Uždarbis

Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services -- Barrons.com

2025-10-30 10:21; UTC

Uždarbis

Cigna Beats Earnings Expectations. The Stock Is Facing Political Uncertainties. -- Barrons.com

2025-10-29 20:14; UTC

Uždarbis

Why CVS Buying Oak Street Health in 2023 Was One of Worst Healthcare Deals in Recent Years -- Barrons.com

2025-10-29 16:00; UTC

Uždarbis

In Medicare, Less Is Now More for Big Insurers -- Heard on the Street -- WSJ

2025-10-29 13:31; UTC

Uždarbis

CVS Posts Loss on Write-Down, Boosts Guidance -- Update

2025-10-29 11:13; UTC

Uždarbis

CVS Health Earnings Are Better Than Expected. Why the Stock Is Falling. -- Barrons.com

2025-10-29 10:46; UTC

Uždarbis

CVS Health Earnings Are Better Than Expected. Why the Stock Is Falling. -- Barrons.com

2025-10-29 10:30; UTC

Uždarbis

CVS Health Raises 2025 View To Adj EPS $6.55-Adj EPS $6.65 >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Adjusted Operating Income $3.46B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health Now Sees 2025 Cash Flow From Operations $7.5B-$8B; Had Seen at Least $7.5B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health Posts 3Q $5.7B Goodwill Impairment Charge Related to Healthcare Delivery Unit >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Front Store Same-Store Sales Up 1.5% >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Healthcare Benefits Segment Revenue $35.99B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Health Services Segment Revenue $49.27B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Same-Store Sales Up 14.3% >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Pharmacy & Consumer Wellness Segment Revenue $36.21B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Pharmacy & Consumer Wellness Segment Revenue Up 11.7% >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Pharmacy Same-Store Sales Up 16.8% >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Rev $102.87B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Loss $3.98B >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health Sees FY Loss/Shr 34c-Loss 24c >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Healthcare Benefits Segment Revenue Up 9.1% >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health Sees FY Adj EPS $6.55-Adj EPS $6.65 >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Loss/Shr $3.13 >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health Sees FY Loss $432M-Loss $307M >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Adj EPS $1.60 >CVS

2025-10-29 10:30; UTC

Uždarbis

CVS Health 3Q Health Services Segment Revenue Up 11.6% >CVS

Akcijų palyginimas

Kainos pokytis

CVS Health Corp. Prognozė

Kainos tikslas

By TipRanks

13.41% į viršų

12 mėnesių prognozė

Vidutinis 88.55 USD  13.41%

Aukščiausias 103 USD

Žemiausias 75 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines CVS Health Corp. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

18

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

65.92 / 68.28Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Rinkos nuotaikos

By Acuity

143 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
help-icon Live chat